Dizhe Pharmaceutical (688192.SH) re-submitted an H share listing application to the Hong Kong Stock Exchange and published the application capital

Zhitongcaijing · 2d ago

Zhitong Financial App News, Dizhe Pharmaceutical (688192.SH) issued an announcement. On August 27, 2026, the company re-submitted an application to the Hong Kong Stock Exchange Limited (hereinafter referred to as the “Hong Kong Stock Exchange”) to issue H shares and list them on the main board of the Hong Kong Stock Exchange, and published the application materials for this issuance and listing on the Hong Kong Stock Exchange website on the same day.